These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26197515)

  • 41. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.
    Marcu A; Schurigt U; Müller K; Moll H; Krauth-Siegel RL; Prinz H
    Eur J Med Chem; 2016 Jan; 108():436-443. PubMed ID: 26708110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.
    Pandey RK; Kumbhar BV; Srivastava S; Malik R; Sundar S; Kunwar A; Prajapati VK
    J Biomol Struct Dyn; 2017 Jan; 35(1):141-158. PubMed ID: 27043972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibiting effects of spermidine derivatives on Trypanosoma cruzi trypanothione reductase.
    O'Sullivan MC; Dalrymple DM; Zhou Q
    J Enzyme Inhib; 1996 Oct; 11(2):97-114. PubMed ID: 9204399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies.
    Tasdemir D; Kaiser M; Brun R; Yardley V; Schmidt TJ; Tosun F; Rüedi P
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1352-64. PubMed ID: 16569852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of lupeol derivatives and their antileishmanial and antitrypanosomal activities.
    Machado VR; Sandjo LP; Pinheiro GL; Moraes MH; Steindel M; Pizzolatti MG; Biavatti MW
    Nat Prod Res; 2018 Feb; 32(3):275-281. PubMed ID: 28715940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the leishmanicidal and cytotoxic effects of inhibitors for microorganism metabolic pathway enzymes.
    de Mesquita Barbosa A; Dos Santos Costa S; da Rocha JR; Montanari CA; Giorgio S
    Biomed Pharmacother; 2015 Aug; 74():95-100. PubMed ID: 26349969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tulbaghia violacea and Allium ursinum Extracts Exhibit Anti-Parasitic and Antimicrobial Activities.
    Krstin S; Sobeh M; Braun MS; Wink M
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29393867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flavonoids and lignans from Virola surinamensis twigs and their in vitro activity against Trypanosoma cruzi.
    Lopes NP; Chicaro P; Kato MJ; Albuquerque S; Yoshida M
    Planta Med; 1998 Oct; 64(7):667-8. PubMed ID: 9810278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-based approach to the identification of a novel group of selective glucosamine analogue inhibitors of Trypanosoma cruzi glucokinase.
    D'Antonio EL; Deinema MS; Kearns SP; Frey TA; Tanghe S; Perry K; Roy TA; Gracz HS; Rodriguez A; D'Antonio J
    Mol Biochem Parasitol; 2015 Dec; 204(2):64-76. PubMed ID: 26778112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altenusin, a biphenyl isolated from the endophytic fungus Alternaria sp., inhibits trypanothione reductase from Trypanosoma cruzi.
    Cota BB; Rosa LH; Caligiorne RB; Rabello AL; Almeida Alves TM; Rosa CA; Zani CL
    FEMS Microbiol Lett; 2008 Aug; 285(2):177-82. PubMed ID: 18557945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thiol redox biology of trypanosomatids and potential targets for chemotherapy.
    Leroux AE; Krauth-Siegel RL
    Mol Biochem Parasitol; 2016; 206(1-2):67-74. PubMed ID: 26592324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trypanosuppressive effects of Kolaviron may be associated with down regulation of Trypanothione reductase in Trypanosoma congolense infection.
    Timothy MR; Ibrahim YKE; Muhammad A; Chechet GD; Aimola IA; Mamman M
    Trop Biomed; 2021 Mar; 38(1):94-101. PubMed ID: 33797530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi.
    Salmon-Chemin L; Lemaire A; De Freitas S; Deprez B; Sergheraert C; Davioud-Charvet E
    Bioorg Med Chem Lett; 2000 Apr; 10(7):631-5. PubMed ID: 10762041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography.
    Baiocco P; Poce G; Alfonso S; Cocozza M; Porretta GC; Colotti G; Biava M; Moraca F; Botta M; Yardley V; Fiorillo A; Lantella A; Malatesta F; Ilari A
    ChemMedChem; 2013 Jul; 8(7):1175-83. PubMed ID: 23733388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug search for leishmaniasis: a virtual screening approach by grid computing.
    Ochoa R; Watowich SJ; Flórez A; Mesa CV; Robledo SM; Muskus C
    J Comput Aided Mol Des; 2016 Jul; 30(7):541-52. PubMed ID: 27438595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insights about resveratrol analogs against trypanothione reductase of
    da Silva AD; Dos Santos JA; Machado PA; Alves LA; Laque LC; de Souza VC; Coimbra ES; Capriles PVSZ
    J Biomol Struct Dyn; 2019 Jul; 37(11):2960-2969. PubMed ID: 30058445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In silico structural characterization of protein targets for drug development against Trypanosoma cruzi.
    Lima CR; Carels N; Guimaraes AC; Tufféry P; Derreumaux P
    J Mol Model; 2016 Oct; 22(10):244. PubMed ID: 27665464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
    Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
    Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.